FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022890001> ?p ?o ?g. }

• W2022890001 endingPage "32" @default.
• W2022890001 startingPage "28" @default.
• W2022890001 abstract "AllergyVolume 54, Issue s58 p. 28-32 Diagnosis of allergic reactions to sulfonamides R. S. Gruchalla, Corresponding Author R. S. Gruchalla Division of Allergy and Immunology, UT Southwestern Medical Center, Dallas, Texas, USA MD, PhD Associate Professor of Internal Medicine Section Chief, Division of Allergy and Immunology UT Southwestern Medical Center 5323 Harry Hines Blvd. Dallas, Texas 75235–8859 USA Tel: 214–648-6370 Fax: 214–648-9100 E-mail: [email protected]Search for more papers by this author R. S. Gruchalla, Corresponding Author R. S. Gruchalla Division of Allergy and Immunology, UT Southwestern Medical Center, Dallas, Texas, USA MD, PhD Associate Professor of Internal Medicine Section Chief, Division of Allergy and Immunology UT Southwestern Medical Center 5323 Harry Hines Blvd. Dallas, Texas 75235–8859 USA Tel: 214–648-6370 Fax: 214–648-9100 E-mail: [email protected]Search for more papers by this author First published: 03 March 2009 https://doi.org/10.1111/j.1398-9995.1999.tb04745.xCitations: 15AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Lazarou J, Pomeranz B, Corey P. Incidence of adverse drug reactions in hospitalized patients - a meta-analysis of prospective studies. JAMA 1998; 279: 1200– 1205. 2 Can A, Swanson C, Penny R, Cooper D. Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with Pneumocystis Carinii pneumonia and AIDS. J Infect Dis 1993; 167: 180– 185. 3 Hennessy S, Strom B, Berlin J. Predicting cutaneous hypersensitivity reactions to cotrimoxazole in HIV-infected individuals receiving primary Pneumocystis carinii pneumonia prophylaxis. J Gen Intern Med 1995; 10: 380– 386. 4 Roujeau J, Stem R. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 19: 1272– 1285. 5 Lancôt K, Ghajar B, Shear N, Naranjo C. Improving the diagnosis of hypersensitivity reactions associated with sulfonamides. J Clin Pharmacol 1994; 34: 1228– 1133. 6 Gordin F, Simon G, Wofsy C, Mills J. Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1984; 100: 495– 499. 7 Coopman S, Johnson R, Piatt R, Stem R. Cutaneous disease and drug reactions in HIV infection. N Engl J Med 1993; 328: 1670– 1674. 8 Arnold P, Guglielmo B, Hollander H. Severe hypersensitivity reaction upon rechallenge with trimethoxazole-sulfamethoxazole in a patient with AIDS. Drug Intel Clin Pharm 1988; 22: 43– 45. 9 Bayard P, Berger T, Jacobson M. Drug hypersensitivity reactions and human immunodeficiency virus disease. J Acquir Immune Defic Syndr 1992; 5: 1237– 1257. 10 Lee B, Safrin S. Interactions and toxicities of drugs used in patients with AIDS. Clin Infect Dis 1992; 14: 773– 779. 11 Greenberger P, Patterson R. Management of drug allergy in patients with acquired immunodeficiency syndrome. J Allergy Clin Immunol 1987; 79: 484– 488. 12 Shear N, Spielberg S. An in vitro lymphocytotoxicity assay for studying adverse reactions to sulfonamides. Br J Dermatol 1985; 28: S112– S113. 13 Rieder M, Uetrecht J, Shear N, Spielberg S. Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfonamides. J Pharmacol Exp Ther 1988; 244: 724– 728. 14 Rieder M, Shear N, Kanee A, Tang B, Spielberg S. Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions. Clin Pharmacol Ther 1991; 49: 13– 17. 15 Carr A, Tindall B, Penny R, Cooper D. In vitro cytoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HTV. Clin Exp Immunol 1993; 94: 21– 25. 16 Meekens C, Sullivan T, Gruchalla R. Immunochemical analysis of sulfonamide drug allergy:identification of sulfamethoxazole-substituted human serum proteins. J Allergy Clin Immunol 1994; 94: 1017– 1024. 17 Koopmans P van der Ven A, Vree T van der Meer J. Pathogenesis of hypersensitivity reactions to drugs in patients with HIV infection:allergic or toxic AIDS 1995; 9: 217– 222. 18 Gruchalla R, Pesenko RD, Do TT, Skiest DJ. Sulfonamide-induced reactions in patients with AIDS - role of covalent protein haptenation. J Allergy Clin Immunol 1998; 101: 371– 378. 19 Rieder M, Uetrecht J, Shear N, Cannon M, Miller M, Spielberg S. Diagnosis of sulfonamide hypersensitivity reactions by in vitro rechallenge with hydroxylamine metabolites of sulfonamides. Ann Intern Med 1989; 110: 286– 289. 20 Cribb A, Speilberg S. Hepatic microsomal metabolism of sulfamethoxazole to hydroxylamine. Drug Metab Dispos 1990; 18: 784– 787. 21 Litt J, Pawlak WA Jr. Drug eruption reference manual. In: J Litt, WA Pawlak, editors. Cleveland : Wal-Zac Enterprises, 1995. 22 Gruchalla R, Sullivan T. Detection of human IgE to sulfamethoxazole by skin testing with sulfamethoxazole poly-L-tyrosine. J Allergy Clin 1991; 88: 784– 792. 23 Kalish R, LaPorte A, Wood J, Johnson K. Sulfonamide-reactive lymphocytes detected at very low frequency in the peripheral blood of patients with drug-induced eruptions. J Allergy Clin Immunol 1994; 94: 465– 472. 24 Mauri-Hellweg D, Bettens F, Mauri D, Brander C, Hunziker T, Pichler W. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin and carbamazepine. J Immunol 1995; 155: 462– 472. 25 Nyfeler B, Pichler W. The lymphocyte transformation test for the diagnosis of drug allergy:sensitivity and specificity. Clin Exp Allergy 1997; 17: 175– 181. 26 Cribb A, Miller M, Leeder I, Hill J, Spielberg S. Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Drug Metab Dispos 1991; 19: 900– 906. 27 Spielberg S. In vitro assessment of pharmacogenetic susceptibility to toxic drug metabolites in humans. Fed Proc 1984; 43: 2308– 1313. 28 Shear N, Spielberg S. In vitro evaluation of a toxic metabolite of sulfadiazine. Can I Physiol Pharmacol 1985; 63: 1370– 1372. 29 Shear N, Speilberg S, Grant D, Tang B, Kalow W. Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Intern Med 1986; 105: 179– 184. 30 Pirmohamed M, Coleman M, Hussain F, Breckenridge A, Park B. Direct and metabolism-dependent toxicity of sulfasalazine and its principal metabolites towards human erythrocytes and leucocytes. Ann Intern Med 1985; 63: 1370– 1372. 31 Wolkenstein P, Charue D, Laurent P, Revuz J, Roujeau J, Bagot M. Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants. Arch Dermatol 1995; 131: 544– 551. 32 Wolkenstein P, Charue D, Laurent P, Revuz J, Roujeau J-C, Bagot M. Metabolic predisposition to cutaneous drug reactions:role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants. Arch Dermatol 1995; 131: 544– 551. 33 Pumford N, Martin B, Thomassen D, et al. Serum antibodies from halothane hepatitis patients react with the rat endoplasmic reticulum protein Erp72. Chem Res Toxicol 1993; 6: 609– 615. 34 Lecder J, Riley R, Cook V, Spielberg S. Human anti-cytochrome P450 antibodies in aromatic anticoavulsant-induced hypersensitivity reactions. J Pharmacol Exp Ther 1992; 263: 360– 367. 35 Cribb A, Pohl L, Spielberg S, Leeder J. Patients with delayed-onset sulfonamide hypersensitivity reactions have antibodies recognizing endoplasmic reticulum luminal proteins. J Pharmacol Exp Ther 1997; 282: 1064– 1072. 36 Cribb A, Nuss C, Alberts D, et al. Covalent binding of sulfamethoxazole reactive metabolites to human and rat liver subcellular fractions assessed by immunochemical detection. Chem Res Toxicol 1999; 9: 500– 507. Citing Literature Volume54, Issues58December 1999Pages 28-32 ReferencesRelatedInformation" @default.
• W2022890001 created "2016-06-24" @default.
• W2022890001 creator A5055345150 @default.
• W2022890001 date "1999-12-01" @default.
• W2022890001 modified "2023-10-16" @default.
• W2022890001 title "Diagnosis of allergic reactions to sulfonamides" @default.
• W2022890001 cites W151650191 @default.
• W2022890001 cites W1521486532 @default.
• W2022890001 cites W1969879564 @default.
• W2022890001 cites W1988282517 @default.
• W2022890001 cites W1995161323 @default.
• W2022890001 cites W1999369567 @default.
• W2022890001 cites W2004772981 @default.
• W2022890001 cites W2005668317 @default.
• W2022890001 cites W2008234609 @default.
• W2022890001 cites W2019608999 @default.
• W2022890001 cites W2020536504 @default.
• W2022890001 cites W2028750556 @default.
• W2022890001 cites W2045874867 @default.
• W2022890001 cites W2051814426 @default.
• W2022890001 cites W2056955303 @default.
• W2022890001 cites W2058391540 @default.
• W2022890001 cites W2064616797 @default.
• W2022890001 cites W2070857907 @default.
• W2022890001 cites W2073645997 @default.
• W2022890001 cites W2074110459 @default.
• W2022890001 cites W2104975435 @default.
• W2022890001 cites W2120113940 @default.
• W2022890001 cites W2123319103 @default.
• W2022890001 cites W2137516211 @default.
• W2022890001 cites W2317624504 @default.
• W2022890001 cites W2336894756 @default.
• W2022890001 cites W4255344524 @default.
• W2022890001 doi "https://doi.org/10.1111/j.1398-9995.1999.tb04745.x" @default.
• W2022890001 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10735646" @default.
• W2022890001 hasPublicationYear "1999" @default.
• W2022890001 type Work @default.
• W2022890001 sameAs 2022890001 @default.
• W2022890001 citedByCount "18" @default.
• W2022890001 countsByYear W20228900012012 @default.
• W2022890001 countsByYear W20228900012017 @default.
• W2022890001 countsByYear W20228900012018 @default.
• W2022890001 countsByYear W20228900012019 @default.
• W2022890001 countsByYear W20228900012020 @default.
• W2022890001 crossrefType "journal-article" @default.
• W2022890001 hasAuthorship W2022890001A5055345150 @default.
• W2022890001 hasConcept C16005928 @default.
• W2022890001 hasConcept C177713679 @default.
• W2022890001 hasConcept C203014093 @default.
• W2022890001 hasConcept C207480886 @default.
• W2022890001 hasConcept C71924100 @default.
• W2022890001 hasConceptScore W2022890001C16005928 @default.
• W2022890001 hasConceptScore W2022890001C177713679 @default.
• W2022890001 hasConceptScore W2022890001C203014093 @default.
• W2022890001 hasConceptScore W2022890001C207480886 @default.
• W2022890001 hasConceptScore W2022890001C71924100 @default.
• W2022890001 hasIssue "s58" @default.
• W2022890001 hasLocation W20228900011 @default.
• W2022890001 hasLocation W20228900012 @default.
• W2022890001 hasOpenAccess W2022890001 @default.
• W2022890001 hasPrimaryLocation W20228900011 @default.
• W2022890001 hasRelatedWork W1997935926 @default.
• W2022890001 hasRelatedWork W2020556773 @default.
• W2022890001 hasRelatedWork W2036275016 @default.
• W2022890001 hasRelatedWork W2093394777 @default.
• W2022890001 hasRelatedWork W2098476153 @default.
• W2022890001 hasRelatedWork W2128179053 @default.
• W2022890001 hasRelatedWork W2397596209 @default.
• W2022890001 hasRelatedWork W2407429859 @default.
• W2022890001 hasRelatedWork W2470112657 @default.
• W2022890001 hasRelatedWork W4297184974 @default.
• W2022890001 hasVolume "54" @default.
• W2022890001 isParatext "false" @default.
• W2022890001 isRetracted "false" @default.
• W2022890001 magId "2022890001" @default.
• W2022890001 workType "article" @default.